Atlas Trials

A Study of the HSP90 Inhibitor AUY922

Clinical trial NCT01485536 · TERMINATED

Trial details

NCT number
NCT01485536
Sponsor
M.D. Anderson Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2012-08-01
Primary completion
2015-11-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.